Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Gemcitabine
Gemcitabine
95058-81-4
|
263.198
|
-0.712
Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer.
2′,2′-difluorodeoxycytidine | 2′-deoxy-2′,2′-difluorocytidine | GEM | Gemcitabine | gemzar
Gemcitabine is a nucleoside metabolic inhibitor used as adjunct therapy in the treatment of certain types of ovarian cancer, non-small cell lung carcinoma, metastatic breast cancer, and as a single agent for pancreatic cancer.
2′,2′-difluorodeoxycytidine | 2′-deoxy-2′,2′-difluorocytidine | GEM | Gemcitabine | gemzar
$19/5 mg
(EBC)
1
We provide 2 compounds for Gemcitabine
Gemcitabine impurity A CRS
6-amino-1,2-dihydropyrimidin-2-one
Cytosine
71-30-7
111.043
-1.846
$50/5 mg
(EBC)
1
Gemcitabine impurity C CRS
1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
2'2'-Difluoro-2'-deoxyuridine
114248-23-6
264.056
-0.698
$89/5 mg
(EBC)
1